Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Patel, Pritesh  [Clear All Filters]
2020
Saraf SL, Ghimire K, Patel P, Sweiss K, Gowhari M, Molokie RE, Gordeuk VR, Rondelli D. Improved health care utilization and costs in transplanted versus non-transplanted adults with sickle cell disease. PLoS One. 2020;15(2):e0229710.
Christian S, Arain S, Patel P, Khan I, Calip GS, Agrawal V, Sweiss K, Griffin S, Cahill K, Konig H, et al. A Multi-institutional Comparison of Mitoxantrone, Etoposide, and Cytarabine (MEC) versus High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia. Am J Hematol. 2020.
2022
Lin Y, Park Y, Khanal A, Campbell-Lee S, Liu L, Chen Z, Patel P, Vidanovic V, Sweiss K, Irene G, et al. A Comparison of Four Leukapheresis Methods to Harvest an Optimal Dose of CD34+ Cells: A Single Center Experience. Eur J Haematol. 2022.
Poudyal BSharma, Tuladhar S, Neupane S, Sapkota S, Pandit S, Shrestha PRaj, Poudel B, Bajaracharya M, Sweiss K, Patel P, et al. Hematopoietic Stem Cell Transplantation in Nepal: international partnership, implementation steps and clinical outcomes. Transplant Cell Ther. 2022.
2024
Maahs L, Patel P, Koshy M, Sweiss K, Chen Z, Xu Z, Aydogan B, Rondelli D. High dose total marrow irradiation (TMI) does not increase long-term toxicity of myeloablative fludarabine/busulfan (FluBu4) conditioning regimen in allogeneic hematopoietic stem cell transplantation (HSCT). Eur J Haematol. 2024.